Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.A new report from the Pharmaceutical Research and Manufacturers Association has found 418 that medicines and vaccines developed through biotechnology are now being tested to treat more than 100 diseases.
Subscribe to our email newsletter
All of the biotechnology medicines and vaccines are now in clinical trials or awaiting approval from the FDA. They include 210 medicines to treat cancer, 50 to treat infectious disease, 44 to treat autoimmune disorders, 22 to treat HIV infection and related conditions, and 22 to treat cardiovascular diseases.
The experimental medicines include monoclonal antibodies that target asthma, lupus and various types of cancer, therapeutic vaccines that are designed to jump-start the immune system to fight diseases such as AIDS and cancer, antisense products being evaluated as potential treatments for cancer and heart disease, and gene therapy testing in cancer and heart disease.
“The biotechnology revolution is giving patients and doctors new hope and new tools to fight disease,” said Billy Tauzin, Pharmaceutical Research and Manufacturers Association (PhRMA) president and CEO. “With mapping of the human genome completed, scientists are now researching the role some discovered genes play in disease and new medicines to treat those diseases. The biotech medicines now in the pipeline are fundamentally changing the way we fight disease.”